ALEC Alector, Inc.

BEARISH Impact: 5/10 Insider Cluster (3 insiders)
Horizon days Filed Mar 2, 2026 Processed 2mo ago
Insider cluster: 3 insiders, $0.2M total
Latest settled — T+20d ⚠ clustered
ALEC ▼ -8.60% at T+20d
SHORT call ✓ call won +8.60% · α vs SPY +0.66% · entry $2.21 → $2.02
Next anchor: T+60d in 5d
Currently $2.06 · +6.79% from $2.21 entry (call sign-flipped)
Entry anchored
Feb 27, 03:59 PM ET
via Databento tick
T+1d
-4.52%
call +4.52% · α +3.61%
$2.11
settled 3mo ago
T+5d
-0.91%
call +0.91% · α -0.30%
$2.19
settled 3mo ago
T+20d
-8.60%
call +8.60% · α +0.66%
$2.02
settled 8w ago
T+60d
call — · α —
in 5d

Price Chart

Loading chart...

Executive Summary

Multiple C-suite executives at Alector, Inc. (ALEC) sold shares in the past week, including CEO Arnon Rosenthal and CFO Neil Lindsay Berkley, realizing a combined total of approximately $244,000 in open-market transactions. The sales represent a coordinated cluster of insider selling by top leadership, though the total value remains small relative to the company's $244M market cap.

Key Financial Metrics

Direction
selling
Total Value
$271.1K
Insiders
3

Actionable Insight

Monitor for upcoming earnings or pipeline updates; this level of C-suite selling may signal lack of confidence in near-term prospects, especially given the low stock price. Watch for further selling or any offsetting buy signals.

Key Facts

  • CEO Arnon Rosenthal sold 81,864 shares for $173,822 in open-market transactions.
  • CFO Neil Lindsay Berkley sold 29,649 shares for $62,954 in open-market transactions.
  • Principal Accounting Officer Grace Wong-Sarad sold 15,517 shares across three days for $34,348 total.
  • All transactions were open-market sales (Form 4 codes 'S'), indicating deliberate liquidity events.
  • Total value of the insider selling cluster: $271,122 over 7 days.

Financial Impact

$271,122 in insider sales over 7 days, representing 0.11% of ALEC's $244M market cap

insider sentimentshareholder confidencepotential dilution risk

Risk Factors

  • Insider selling by CEO and CFO can erode investor confidence, particularly in a small-cap biotech with no commercial revenue.
  • Proceeds from sales may indicate personal financial needs or broader concerns about company trajectory.

Market Snapshot

Exchange
Nasdaq

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CONTEXT: Insider Cluster Data (5 trades, 7d window)cluster-ALEC-1772578910982
4 reports for ALEC
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for ALEC — sortable, filterable
Type Now
May 7, 2026
13d ago
8-K
BEARISH ★ 6/10
$2.10 $2.30▼ −9.52%▼ −8.06%$2.06 (+1.90%)
Mar 12, 2026
9w ago
S-3
BEARISH ★ 7/10
$2.20 $2.05▲ +6.82%▲ +4.70%$2.06 (+6.36%)
Mar 2, 2026
11w ago
Insider Cluster
BEARISH ★ 5/10
$2.21 $2.19▲ +0.91%▼ −0.30%$2.06 (+6.79%)
Feb 26, 2026
12w ago
Insider Cluster
NEUTRAL ★ 3/10
$2.56 $1.98▼ −22.66%▼ −21.53%$2.06 (−19.53%)
Showing 4 of 4

US Market Status

Market Open — Closes in 4h 38m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access